2017
DOI: 10.1016/j.wneu.2017.03.070
|View full text |Cite
|
Sign up to set email alerts
|

Stentriever Thrombectomy Failure: A Challenge in Stroke Management

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
12
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 28 publications
(14 citation statements)
references
References 22 publications
2
12
0
Order By: Relevance
“…Three recent cohort studies found that the successful reperfusion rate of RS following failed MT was 64.6–83.3%, the good outcome rate was 35.3–56.5%, the sICH rate was 4.3–16.7%, and the mortality rate was 4.3–23.5%. Thus, the results in patients who underwent RS after failed MT were superior to those for patients who did not undergo RS after MT failure 10–12. The proportions of favorable outcomes and sICH in patients in the present study who underwent RS were similar to those in previous studies,10–12 although there was a higher incidence of mortality.…”
Section: Discussionsupporting
confidence: 78%
See 2 more Smart Citations
“…Three recent cohort studies found that the successful reperfusion rate of RS following failed MT was 64.6–83.3%, the good outcome rate was 35.3–56.5%, the sICH rate was 4.3–16.7%, and the mortality rate was 4.3–23.5%. Thus, the results in patients who underwent RS after failed MT were superior to those for patients who did not undergo RS after MT failure 10–12. The proportions of favorable outcomes and sICH in patients in the present study who underwent RS were similar to those in previous studies,10–12 although there was a higher incidence of mortality.…”
Section: Discussionsupporting
confidence: 78%
“…Thus, the results in patients who underwent RS after failed MT were superior to those for patients who did not undergo RS after MT failure 10–12. The proportions of favorable outcomes and sICH in patients in the present study who underwent RS were similar to those in previous studies,10–12 although there was a higher incidence of mortality. The median time from onset to puncture was longer in the present study, which may be an important reason for the higher mortality risk.…”
Section: Discussionsupporting
confidence: 78%
See 1 more Smart Citation
“…The Interventional Management of Stroke (IMS) 1 and 2 trials41 42 gave relatively reliable data on the efficacy and safety of intra-arterial alteplase administration with SICH rates of 6.3–9.9% but the efficacy for thrombectomy resistant thrombi must be questioned. Additionally, rescue intra-arterial infusion of tirofiban alone was shown to be relatively ineffective by Barranchini et al 27 who demonstrated in a European population that only 3 of 19 patients attained successful reperfusion with intra-arterial tirofiban infusion after failed thrombectomy. Just as stent retrievers represented an evolutionary leap in the treatment of ELVO over the Merci device,43 44 more recently a newer generation of devices, including Embotrap (Ceronovus), have been developed with the aim of facilitating the removal of more resistant thrombi but the real world efficacy compared with traditional stent retrievers is as yet untested.…”
Section: Discussionmentioning
confidence: 99%
“…The Enterprise® stent and Solitaire™ AB are self-expanding closed-cell stents, which were initially designed to assist in the coiling of brain aneurysms. They have been employed as a revascularization device for use in AIS after other devices have failed [5, 17]. While the closed cell design provides good radial force, a study using the Enterprise® for primary stenting during AIS suggested that balloon angioplasty after stent deployment was required in 45% of the cases [10].…”
Section: Discussionmentioning
confidence: 99%